Lexington Herald Leader Logo

Experimental vaccine shows promise vs. dengue | Lexington Herald Leader

×
  • E-edition
  • Home
    • All News
    • Business
    • Communities
    • Counties
    • Crime
    • Education
    • Lexington
    • Local
    • Most Wanted
    • Nation/World
    • News Photos
    • News Videos
    • Politics
    • Searchable Databases
    • State
    • Watchdog
    • Columns
    • Tom Eblen
    • All Sports
    • UK Sports
    • College Sports
    • Next Cats Recruiting
    • High School
    • Horses
    • Kentucky Speedway
    • Lexington Legends
    • Reds
    • MLB
    • NBA
    • NASCAR
    • NFL
    • Sports Photos
    • Sports Videos
    • Columns
    • John Clay's Columns
    • Mark Story
    • Next Cats Recruiting
    • All UK Sports
    • Next Cats Recruiting
    • Baseball
    • Basketball - Men
    • Basketball - Women
    • Recruiting
    • Ex-Cats
    • Football
    • UK Photos
    • UK Videos
    • More UK Sports
    • Columns
    • John Clay's Blog
    • Mark Story
    • Politics
    • Elections
    • All Entertainment
    • Books
    • Celebrities
    • Comics
    • Puzzles & Games
    • Events Calendar
    • Horoscopes
    • Movies
    • Music
    • Restaurants
    • Stage & Dance
    • TV
    • Visual Arts
    • Entertainment Photos
    • Entertainment Videos
    • News Blogs
    • Kentucky Weather
    • Photo Archive
    • Sports Blogs
    • John Clay's Blog
    • High School
    • UK Football
    • UK Men's Basketball
    • UK Women's Basketball
    • Lexington Legends
    • Entertainment Blogs
    • Walter Tunis on Music
    • All Opinion
    • Editorials
    • Joel Pett
    • Letters to the Editor
    • National Columnists
    • Op-Ed
    • Submit a Letter
    • All Living
    • Celebrations
    • Family
    • Fashion
    • Food & Drink
    • Fru-Gal: Deb Morris
    • Health & Medicine
    • Home & Garden
    • Paul Prather
    • Religion
    • Travel
    • Readers' Choice
    • Kentucky Obituaries
    • Obituaries in the News
    • Submit an Obituary
    • Customer Service
    • Contact Us
    • About Us
    • E-edition
    • Page Reprints
    • Photo Reprints
    • RSS Feeds
    • Special Sections
    • Site Information
    • Advertise With Us
    • Archives
    • Mobile
    • Mobile Apps & eReaders
    • Newsletters
    • Social
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • Google+
    • Today's Circulars
    • Classifieds
    • Jobs
    • Cars
    • Homes
    • Homeseller
    • Legal Notices
  • Place an Ad
  • Mobile & Apps

Nation & World

Experimental vaccine shows promise vs. dengue

By DONALD G. McNEIL Jr.

The New York Times

    ORDER REPRINT →

March 22, 2016 07:53 AM

An experimental dengue vaccine worked almost perfectly in a small trial in which volunteers were deliberately given a mild form of the disease, scientists said last week.

The results in 41 volunteers were so encouraging that they justified starting a larger trial, now underway in Brazil. The vaccine was jointly developed by the National Institute of Allergy and Infectious Diseases, and the Food and Drug Administration.

In the study, published in Science Translational Medicine, 41 volunteers were given the vaccine, now named TV003, or a placebo.

Six months later, all were “challenged” — deliberately infected — with a genetically modified strain of dengue virus from Tonga that can cause only mild disease.

Sign Up and Save

Get six months of free digital access to the Lexington Herald-Leader

SUBSCRIBE WITH GOOGLE

#ReadLocal

No replicating virus was found in the blood of any of the 21 volunteers who received the vaccine. Dengue was found in the blood of all 20 who had the placebo, and many developed signs of infection, such as rashes and low levels of white blood cells.

There are four dengue viruses, or serotypes, all spread by Aedes aegypti, the mosquito that spreads the Zika virus.

Every year, nearly 400 million people around the world get dengue. Most recover and become immune to the first serotype they had.

But about 2 million who later become infected with a different serotype develop dangerous hemorrhagic fevers, and about 25,000 die from them each year.

One of several dengue vaccines in development, Dengvaxia, has recently been licensed in Mexico. But it offers relatively little protection against some serotypes and may make some young children who receive it more likely to be hospitalized years later.

“Dengue is unique, and if you don’t do it right, you can do more harm than good,” said Dr. Anna P. Durbin, a researcher at Johns Hopkins Bloomberg School of Public Health who led the testing of TV003.

Because dengue is from the same family as the Zika virus, the techniques used to make TV003 might be applicable to a Zika vaccine, she said.

  Comments  

Videos

Trapped people rescued from SeaWorld ride

‘Pretty epic:’ The exhilaration of bombing down ski runs in 500 inches of total snowfall

View More Video

Trending Stories

‘It’s a good day to die.’ Man pulls gun on couple wearing MAGA caps at Kentucky Sam’s Club

February 18, 2019 02:29 PM

Sayre School to honor ‘two remarkable young men’ killed in car crash.

February 18, 2019 12:52 PM

Curse of Saratoga strikes again? Another Chevy Chase restaurant closes in Lexington.

February 19, 2019 12:19 PM

Kentucky students need border wall before a new middle school, Sen. Lindsey Graham says.

February 18, 2019 11:41 AM

Two killed in Interstate 64 collision in Frankfort

February 18, 2019 11:01 AM

Read Next

Trump wants California to pay back billions for bullet train

Business

Trump wants California to pay back billions for bullet train

By KATHLEEN RONAYNE Associated Press

    ORDER REPRINT →

February 20, 2019 12:18 AM

The Trump administration plans to cancel $929 million in U.S. money for California's beleaguered high-speed rail project and wants the state to return an additional $2.5 billion it's already spent.

KEEP READING

Sign Up and Save

#ReadLocal

Get six months of free digital access to the Lexington Herald-Leader

SUBSCRIBE WITH GOOGLE

MORE NATION & WORLD

Where the investigations related to President Trump stand

National

Where the investigations related to President Trump stand

February 20, 2019 12:25 AM
Border wall, bullet train: California vs. Trump escalates

National

Border wall, bullet train: California vs. Trump escalates

February 20, 2019 12:25 AM
Japan trade deficit highest in 5 yrs, hit by China doldrums

Business

Japan trade deficit highest in 5 yrs, hit by China doldrums

February 20, 2019 12:20 AM
Possible peace declaration looms large over Kim-Trump summit

Business

Possible peace declaration looms large over Kim-Trump summit

February 20, 2019 12:31 AM

National

AP News in Brief at 12:04 a.m. EST

February 20, 2019 12:04 AM
Deadly crackdown stokes fear among protesters in Venezuela

World

Deadly crackdown stokes fear among protesters in Venezuela

February 20, 2019 12:01 AM
Take Us With You

Real-time updates and all local stories you want right in the palm of your hand.

Icon for mobile apps

Lexington Herald Leader App

View Newsletters

Subscriptions
  • Start a Subscription
  • Customer Service
  • eEdition
  • Vacation Hold
  • Pay Your Bill
  • Rewards
Learn More
  • About Us
  • Contact Us
  • Newsletters
  • News in Education
  • Archives
Advertising
  • Contact Us
  • Place a Classified Ad
  • Local Deals
  • Digital Solutions
  • Media Kit
Copyright
Privacy Policy
Terms of Service


Back to Story